Millennium Predicts Six New Pharmacogenomic Programs for 02; Promises Another Acquisition | GenomeWeb

SAN FRANCISCO, Jan. 9 - Millennium Pharmaceuticals plans to expand its pharmacogenomics discovery to where it has as many as six new clinical programs, the company's chairman and CEO said here on Wednesday.


Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.

In Science this week: convergent evolution in bird hemoglobin, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.